Novartis

Novartis is a Swiss pharmaceutical company headquartered in Basel. It was created in 1996 by the merger of Ciba-Geigy and Sandoz, two older Basel chemical and drug firms. The company is among the biggest drugmakers in the world. It reports results in dollars and trades on the SIX Swiss Exchange. It employs thousands of researchers in Basel, New Jersey and other places.

The company researches and sells prescription medicines for heart disease, cancer, immune disorders and eye and nervous system conditions. Products include Entresto, Cosentyx and Kisqali. It spun off its generics business, Sandoz, in 2023 and earlier sold its consumer health stake.

Novartis has research centers in Basel, Cambridge in Massachusetts and other sites. It sells medicines in about 140 countries. The shares trade on the Swiss exchange and the New York Stock Exchange. Vas Narasimhan has led the company since 2018. It has been building a focus on radioligand therapy for cancer. Competitors include Roche, Pfizer and Merck.